ARANZ Medical recognized in multiple awards

cdhb-diabetes

Canterbury DHB diabetes podiatrist Rachael McBrydie uses ARANZ Medical’s Silhouette system in her assessment of a wound.

Christchurch company ARANZ Medical is being recognized as an innovator whose solutions are transforming the process of skin assessment in healthcare. This year, AML has been named a finalist in the Hi-Tech Awards, the Champion Canterbury Awards, the American Chamber of Commerce NZ Awards, and selected as the NZ Health and Environment category entry of the World Summit Awards recognizing information and communication technology in the development of communities. Frost & Sullivan (F&S) awarded AML the 2014 New Zealand Medical Imaging New Product Innovation Leadership Award for its pioneering work in wound assessment.

ARANZ Medical’s 3D scanning and information systems support better healthcare outcomes in skin assessment. Innovations include Silhouette®, an FDA-approved electronic wound assessment system, and FastSCAN II, a 3D scanning system for orthotics and prosthetics. The company’s growth is driven by increases in diseases like diabetes, an ageing population, and more accountable healthcare.